Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV.
Over 3000 patients were died in sub Saharan Africa due to HIV in 2015. Following 10 countries from Africa consists of 80% of total HIV burden which are South Africa, Kenya, Malawi, Ethiopia, Mozambique, United Republic of Tanzania, Nigeria, Uganda, Zimbabwe and Zambia.
The report details the trend, potential and market size of HIV Diagnosis and Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of HIV Diagnosis and Treatmentmarket, defines the market attractiveness level of HIV Diagnosis and Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of HIV Diagnosis and Treatment industry, describes the types of HIV Diagnosis and Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global HIV Diagnosis and Treatment market and the development prospects and opportunities of HIV Diagnosis and Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global HIV Diagnosis and Treatment market in Chapter 13.
By Player:
GlaxoSmithKline
Bristol-Myers Squibb
Johnson & Johnson
Cipla
Gilead
Abbott Laboratories
F Hoffmann-La Roche
Boehringer Ingelheim
By Type:
ELISA Test
Saliva Tests
Viral Load Test
Western Blot
Others
By End-User:
Hospitals
Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 HIV Diagnosis and Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 HIV Diagnosis and Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 HIV Diagnosis and Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 HIV Diagnosis and Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise HIV Diagnosis and Treatment Market Analysis and Outlook to 2022
-
7.1 Global HIV Diagnosis and Treatment Consumption (2017-2022)
-
7.2 United States HIV Diagnosis and Treatment Consumption (2017-2022)
-
7.3 Europe HIV Diagnosis and Treatment Consumption (2017-2022)
-
7.4 China HIV Diagnosis and Treatment Consumption (2017-2022)
-
7.5 Japan HIV Diagnosis and Treatment Consumption (2017-2022)
-
7.6 India HIV Diagnosis and Treatment Consumption (2017-2022)
-
7.7 South Korea HIV Diagnosis and Treatment Consumption (2017-2022)
8 Region and Country-wise HIV Diagnosis and Treatment Market Analysis and Outlook to 2028
-
8.1 Global HIV Diagnosis and Treatment Consumption Forecast (2022-2028)
-
8.2 United States HIV Diagnosis and Treatment Consumption Forecast (2022-2028)
-
8.3 Europe HIV Diagnosis and Treatment Consumption Forecast (2022-2028)
-
8.4 China HIV Diagnosis and Treatment Consumption Forecast (2022-2028)
-
8.5 Japan HIV Diagnosis and Treatment Consumption Forecast (2022-2028)
-
8.6 India HIV Diagnosis and Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea HIV Diagnosis and Treatment Consumption Forecast (2022-2028)
9 Global HIV Diagnosis and Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global HIV Diagnosis and Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global ELISA Test Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Saliva Tests Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Viral Load Test Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Western Blot Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global HIV Diagnosis and Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
10 Global HIV Diagnosis and Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global HIV Diagnosis and Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global ELISA Test Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Saliva Tests Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Viral Load Test Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Western Blot Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global HIV Diagnosis and Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global HIV Diagnosis and Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global HIV Diagnosis and Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global HIV Diagnosis and Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 HIV Diagnosis and Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global HIV Diagnosis and Treatment Market Competitive Analysis
-
14.1 GlaxoSmithKline
-
14.1.1 GlaxoSmithKline Company Details
-
14.1.2 GlaxoSmithKline HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline HIV Diagnosis and Treatment Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb HIV Diagnosis and Treatment Product and Service
-
14.3 Johnson & Johnson
-
14.3.1 Johnson & Johnson Company Details
-
14.3.2 Johnson & Johnson HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Johnson & Johnson HIV Diagnosis and Treatment Product and Service
-
14.4 Cipla
-
14.4.1 Cipla Company Details
-
14.4.2 Cipla HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Cipla HIV Diagnosis and Treatment Product and Service
-
14.5 Gilead
-
14.5.1 Gilead Company Details
-
14.5.2 Gilead HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Gilead HIV Diagnosis and Treatment Product and Service
-
14.6 Abbott Laboratories
-
14.6.1 Abbott Laboratories Company Details
-
14.6.2 Abbott Laboratories HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Abbott Laboratories HIV Diagnosis and Treatment Product and Service
-
14.7 F Hoffmann-La Roche
-
14.7.1 F Hoffmann-La Roche Company Details
-
14.7.2 F Hoffmann-La Roche HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 F Hoffmann-La Roche HIV Diagnosis and Treatment Product and Service
-
14.8 Boehringer Ingelheim
-
14.8.1 Boehringer Ingelheim Company Details
-
14.8.2 Boehringer Ingelheim HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Boehringer Ingelheim HIV Diagnosis and Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of HIV Diagnosis and Treatment
-
Figure HIV Diagnosis and Treatment Picture
-
Table Global HIV Diagnosis and Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global HIV Diagnosis and Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global HIV Diagnosis and Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global HIV Diagnosis and Treatment Consumption by Country (2017-2022)
-
Figure United States HIV Diagnosis and Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe HIV Diagnosis and Treatment Consumption and Growth Rate (2017-2022)
-
Figure China HIV Diagnosis and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan HIV Diagnosis and Treatment Consumption and Growth Rate (2017-2022)
-
Figure India HIV Diagnosis and Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea HIV Diagnosis and Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global HIV Diagnosis and Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States HIV Diagnosis and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe HIV Diagnosis and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China HIV Diagnosis and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan HIV Diagnosis and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India HIV Diagnosis and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea HIV Diagnosis and Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ELISA Test Consumption and Growth Rate (2017-2022)
-
Figure Global Saliva Tests Consumption and Growth Rate (2017-2022)
-
Figure Global Viral Load Test Consumption and Growth Rate (2017-2022)
-
Figure Global Western Blot Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global ELISA Test Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Saliva Tests Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Viral Load Test Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Western Blot Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global HIV Diagnosis and Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global HIV Diagnosis and Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline HIV Diagnosis and Treatment Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb HIV Diagnosis and Treatment Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson HIV Diagnosis and Treatment Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla HIV Diagnosis and Treatment Product and Service
-
Table Gilead (Foundation Year, Company Profile and etc.)
-
Table Gilead HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead HIV Diagnosis and Treatment Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories HIV Diagnosis and Treatment Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche HIV Diagnosis and Treatment Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim HIV Diagnosis and Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim HIV Diagnosis and Treatment Product and Service
-
